These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7510913)

  • 1. Ultrasonic volume monitoring in patient with prostate cancer treated by external beam radiation therapy.
    Saitoh M; Ramirez E; Babaian RJ
    Urology; 1994 Mar; 43(3):342-8. PubMed ID: 7510913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy.
    D'Amico AV; Propert KJ
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):273-9. PubMed ID: 8635933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of residual neoplasm in the prostate following three-dimensional conformal radiotherapy.
    Forman JD; Oppenheim T; Liu H; Montie J; McLaughlin PW; Porter AT
    Prostate; 1993; 23(3):235-43. PubMed ID: 7694267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
    Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
    Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen cancer volume: a significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapy.
    Lankford SP; Pollack A; Zagars GK
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):327-33. PubMed ID: 9226319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen spikes after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):450-6. PubMed ID: 12243821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of small (less than 0.2 cm3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels less than 10 ng/mL.
    Fleshner NE; O'Sullivan M; Premdass C; Fair WR
    Urology; 1999 Feb; 53(2):356-8. PubMed ID: 9933054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of external beam radiation therapy on serum prostate-specific antigen.
    Chodak GW; Neumann J; Blix G; Sutton H; Farah R
    Urology; 1990 Apr; 35(4):288-94. PubMed ID: 1690936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fall and rise of prostate-specific antigen. Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer.
    Zagars GK; Pollack A
    Cancer; 1993 Aug; 72(3):832-42. PubMed ID: 7687516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate.
    D'amico AV; Tempany CM; Schultz D; Cormack RA; Hurwitz M; Beard C; Albert M; Kooy H; Jolesz F; Richie JP
    Urology; 2003 Dec; 62(6):1063-7. PubMed ID: 14665356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.
    Martinez A; Gonzalez J; Stromberg J; Edmundson G; Plunkett M; Gustafson G; Brown D; Yan D; Vicini F; Brabbins D
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1019-27. PubMed ID: 7493828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free-to-total prostate-specific antigen ratios 18-24 months following external beam radiation for adenocarcinoma of the prostate.
    Ward JF; Johnstone PA; Kane CJ
    J Surg Oncol; 1999 Feb; 70(2):91-4. PubMed ID: 10084650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.
    Stromberg J; Martinez A; Gonzalez J; Edmundson G; Ohanian N; Vicini F; Hollander J; Gustafson G; Spencer W; Yan Di
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):161-71. PubMed ID: 7543891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is prostate specific antigen density an important prognostic indicator for patients with prostate cancer treated with external beam therapy?
    Aref I; Eapen L; Agboola O; Cross P
    Br J Radiol; 1998 Aug; 71(848):868-71. PubMed ID: 9828800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of prostatic volume and prostate specific antigen (PSA) in patients with advanced prostatic cancer treated by castration.
    Okihara K; Watanabe H; Saitoh M; Kojima M
    Tohoku J Exp Med; 1998 May; 185(1):37-44. PubMed ID: 9710944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
    Kuban D; Thames H; Levy L; Horwitz E; Kupelian P; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):409-14. PubMed ID: 15667960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.